Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page
- Check4 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, with a minimal header and a Home link. The previous study details and sections appear to be removed.SummaryDifference18%

- Check46 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor refresh of the entry that does not modify study data, eligibility criteria, or results.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer revision. This is a metadata update rather than a substantive change to the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision label updated to v3.6.4, replacing the previous v3.6.3. This indicates a minor maintenance update to the page’s versioning.SummaryDifference0.1%

- Check103 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new patch/version was applied to the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.